TKIs work by binding to the active site of tyrosine kinases, thereby preventing the phosphorylation process essential for signal transduction. This inhibition disrupts various cellular processes that contribute to tumor growth and survival. TKIs can be selective, targeting specific tyrosine kinases, or non-selective, affecting multiple kinases. The specificity of a TKI can influence its efficacy and side effect profile.
